Basidiolipids from Agaricus are novel immune adjuvants

Immunobiology

Volumn 200, Issue 2, 1999, Pages 277-289

  Jennemann, Richard ^a   Bauer, Bernhard L ^a   Bertalanffy, Helmut ^a   Selmer, Thorsten ^a   Wiegandt, Herbert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; IMMUNOGLOBULIN; LIPID; SAPONIN;

AGARICALES; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BASIDIOMYCETES; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; MUSHROOM; NONHUMAN; PRIORITY JOURNAL;

EID: 0032970011     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(99)80076-X     Document Type: Article

References (15)

1. WANG, H. X., T. B. NG, V. E. OOI, W. K. LIU, and S. T. CHANG. 1996. A polysaccharide-peptide complex from cultured mycelia of the mushroom Tricholoma mongolicum with immunoenhancing and antitumor activities. Biochem. Cell Biol. 74: 95.
2. ITO, H., K. SHIMURA, H. ITOH, and M. KAWADE. 1997. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) «Himamatsutake» and its mechanism in tumor-bearing mice. Anticancer Res. 17: 277.
3. MIZUNO, M., M. MORIMOTO, K. MINATO, and H. TSUCHIDA. 1998. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci. Biotechnol. Biochem. 62: 434.
4. FUJIMIYA, Y., Y. SUZUKI, K. OSHIMAN, H. KOBORI, K. MORIGUCHI, H. NAKASHIMA, Y. MATUMOTO, S. TAKAHARA, T. EBINA, and R. KATAKURA. 1998. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation. Cancer Immunol. Immunother. 46: 147.
5. JENNEMANN, R., B. L. BAUER, H. BERTALANFFY, R. GEYER, R. M. GSCHWIND, T. SELMER, and H. WIEGANDT. 1999. Novel glycoinositolphosphosphingolipids, basidiolipids, from Agaricus. Eur. J. Biochem. 259: 331-338.
6. KENSIL, C. R., U. PATEL, M. LENNICK, and D. MARCIANI. 1991. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146: 431.
7. SO, H.-S., H.-S. YOON, D.-Y. CHOE, Y.-S. KWON, J.-H. SUNG, T. G. LEE, E.-S. PARK, H.-S. CHO, B. M. LEE, J. M. CHO, and W.-S. RYU. 1997. Effect of a novel saponin adjuvant derived from Quillaja saponaria on the immune response to recombinant hepatitis B surface antigen. Mol. Cells 7: 178.
8. JENNEMANN, R., C. GNEWUCH, S. BOSSLET, B. L. BAUER, and H. WIEGANDT. 1994. Specific immunization using keyhole limpet hemocyanin-ganglioside conjugates. J. Biochem. 115: 1047.
9. JENNEMANN, R., B. L. BAUER, R. SCHMIDT, H.-P. ELSÄSSER, and H. WIEGANDT. 1996. Effects of monophosphoryllipid-A on the immunization of mice with keyhole limpet hemocyanin-and muramyldipeptide-ganglioside Gfpt1 conjugates. J. Biochem. 119: 378.
10. WARREN, H. S., F. R. VOGEL, and L. A. CHEDID. 1986. Current status of immunological adjuvants. Ann. Rev. Immunol. 4: 369.
11. GUPTA, R. K., E. H. RELYVELD, E. B. LINDBLAD, B. BIZZINI, S. BEN-EFRAIM, and C. K. CUPTA. 1993. Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 11: 293.
12. GUPTA, R. K. and G. R. SIBER. 1995. Adjuvants for human vaccines - current status, problems and future aspects. Vaccine 13: 1263.
13. WERNER, G. H. and P. JOLLES. 1996. Immunostimulating agents: what next? - a review of their present and potential medical applications. Eur. J. Biochem. 242: 1.
14. HELLING, F., A. SHANG, M. CALVES, S. ZHANG, S. REN, R. K. YU, H. OETTGEN, and P. O. LIVINGSTON. 1994. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 54: 197.
15. α14 NKT cells by glycosylceramides. Science. 278: 1626